Syndax Pharmaceuticals, Inc. (SNDX)
NASDAQ: SNDX · Real-Time Price · USD
14.44
+1.34 (10.23%)
Nov 3, 2026, 3:38 PM EST - Market open
Syndax Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -209.48 | -285.42 | -318.76 | -209.36 | -149.34 | 24.93 |
Depreciation & Amortization | 0.02 | 0.01 | 0.01 | 0.01 | 0.03 | 0.04 |
Other Amortization | 0.54 | 0.23 | 0.03 | - | - | - |
Loss (Gain) From Sale of Investments | -4.69 | -10.75 | -13.47 | -14.8 | -3.38 | 0.64 |
Stock-Based Compensation | 52.61 | 47.5 | 43.03 | 30.95 | 16.02 | 13.32 |
Provision & Write-off of Bad Debts | - | 3.67 | - | - | - | - |
Other Operating Activities | 2.67 | 1.11 | 0.99 | 0.74 | 1.34 | -0.2 |
Change in Accounts Receivable | -21.46 | -30.39 | -7.6 | - | - | - |
Change in Inventory | -14.04 | -32.09 | -0.37 | - | - | - |
Change in Accounts Payable | -10.25 | 4.95 | 1.67 | 5.61 | -1.32 | 2.16 |
Change in Unearned Revenue | - | - | - | - | - | -13.13 |
Change in Other Net Operating Assets | 26.74 | -21.79 | 19.57 | 26.25 | 2.98 | 1.38 |
Operating Cash Flow | -177.36 | -322.98 | -274.9 | -160.6 | -133.68 | 29.13 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -0.1 | -0.19 | - | - | - | -0.13 |
Sale of Property, Plant & Equipment | - | - | - | - | 0.23 | - |
Investment in Securities | -73.32 | 290.22 | -219.78 | 117.61 | -186.41 | -40.74 |
Investing Cash Flow | -73.42 | 290.04 | -219.78 | 117.61 | -186.19 | -40.87 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Repaid | - | - | - | - | -21 | - |
Net Debt Issued (Repaid) | 243.84 | - | - | - | -21 | - |
Issuance of Common Stock | 25.96 | 13.68 | 9.72 | 278.18 | 193.25 | 117.89 |
Other Financing Activities | - | - | 343.65 | -14.04 | - | 0.58 |
Financing Cash Flow | 269.79 | 13.68 | 353.37 | 264.13 | 172.25 | 118.46 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Cash Flow | 19.02 | -19.27 | -141.31 | 221.14 | -147.61 | 106.72 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -177.46 | -323.17 | -274.9 | -160.6 | -133.68 | 29 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -61.26% | -187.50% | -1160.91% | - | - | 20.76% |
Free Cash Flow Per Share | -2.00 | -3.73 | -3.21 | -2.28 | -2.20 | 0.54 |
Levered Free Cash Flow | -113.03 | -209.8 | -155.26 | -82.37 | -76.27 | 32.03 |
Unlevered Free Cash Flow | -84.14 | -188.92 | -152.21 | -82.24 | -74.31 | 33.22 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | 16.74 | - | - | - | 2.06 | 2 |
Change in Working Capital | -19.01 | -79.32 | 13.27 | 31.86 | 1.66 | -9.6 |